Efficacy and safety of non-conventional synthetic disease-modifying antirheumatic drugs in early active rheumatoid arthritis: a network meta-analysis
Year: 2025
Type: article
Language: en
Topic: Rheumatoid Arthritis Research and Therapies
Authors and affiliations:
raw_author_name: Haimei Xu
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Chen Li
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Rui Ding
raw_affiliation_strings: Clinical Trial Institution, Peking University People's Hospital, Beijing, China
raw_author_name: Yaoxuan Zhan
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Haiyan Liu
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Xintong Liang
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Yuanchen Niu
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Ying Luo
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Zhiqin Hu
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Jin He
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Liming Chen
raw_affiliation_strings: Clinical Trial Institution, Peking University People's Hospital, Beijing, China. clm1003@163.com
Clinical Trial Institution, Peking University People's Hospital, Beijing, China
raw_author_name: Tenghua Wang
raw_affiliation_strings: Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. wangtenghua88@126.com
Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
raw_author_name: Yi Fang
raw_affiliation_strings: Clinical Trial Institution, Peking University People's Hospital, Beijing, China. phaseistudy@163.com
Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China. phaseistudy@163.com
Guangdong Engineering Research Center of Early Clinical Trials of Biotechnology Drugs, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
Clinical Trial Institution, Peking University People's Hospital, Beijing, China